SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
27-Jan-23 4:44 PM View: | Metacrine, Inc. (MTCR) | 26-Jan-23 | Sale | 107,054 | $0.41 | $44,331.10 | (51%) 210.55K to 103.5K | |
01-Mar-22 10:00 PM View: | Metacrine, Inc. (MTCR) | 27-Feb-22 | Grant | 210,553 | -- | -- | 100% 0 to 210.55K | |
24-May-21 6:10 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 20-May-21 | Grant | 2,897 | $2.80 | $8,111.60 | 70% 4.16K to 7.06K | |
23-Nov-20 6:40 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 20-Nov-20 | Grant | 2,662 | $3.00 | $7,986.00 | 177% 1.5K to 4.16K | |
11-Dec-18 4:18 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 11-Dec-18 | Purchase | 1,500 | $3.88 | $5,820.00 | 100% 0 to 1.5K |